Skip to main content

Vagus Nerve Simulation For ADHD Symptom Management: Research Guide Published

The development team at Pulsetto have published the results of their research into whether vagus nerve stimulation (VNS) could help those with ADHD improve their focus and impulse control.

The newly released research results suggest that the vagus nerve’s links to cognitive functionality could improve focus and reduce hyperactivity in those individuals with ADHD. Pulsetto believes that the results of this alternative non-invasive method will likely be welcomed by the ADHD community, who have traditionally relied on medication to manage their symptoms.

Further information is available at https://pulsetto.tech/blogs/blog/vagus-nerve-stimulation-for-adhd-do-exercises-non-invasive-treatment-work

ADHD, or attention deficit hyperactivity disorder, affects an estimated 15.5 million U.S. adults, according to the Centers for Disease Control and Prevention (CDC). However, the actual number is thought to be much higher, Pulsetto explains, because of previous generational ignorance of the condition and the fact that ADHD symptoms are often masked in women, leading to later-in-life diagnosis.

For the purposes of their study, Pulsetto’s research team took into account the three main categories of ADHD affecting Americans. Firstly, inattentive ADHD which is characterized by an inability to stay focused. Secondly, hyperactive-impulse type ADHD which is usually marked by excessive fidgeting and poor impulse control. And finally, combined ADHD which manifests with symptoms found in both of the previous categories.

Pulsetto’s research suggests that “by rebalancing the autonomic nervous system and modulating brain activity, vagus nerve stimulation can help alleviate some of the core symptoms of ADHD”. In particular, the company cites VNS’s already proven ability to improve focus in non-ADHD people. They also witnessed a substantial reduction in hyperactive and impulse control behaviors, which are linked to the body’s “fight or flight” response — another area of the mind-body symbiosis which is controlled by the vagus nerve.

“This research gives hope to many ADHD sufferers who are looking for a drug-free, non-invasive way to supplement their existing treatment plan,” said a spokesperson for Pulsetto. “We found that those who used Pulsetto’s vagus nerve stimulation device had the most consistent results. The guided meditations and calming acoustics in the accompanying app also acted as a way to calm the mind and create focus.”

Pulsetto’s vagus nerve stimulation device is FCC and CE certified, ensuring it meets strict safety standards. Whilst vagus nerve stimulation (VNS) is considered safe for most users, those with ADHD or other underlying health conditions should consult a medical practitioner before starting VNS sessions.

Those interested in learning more about how vagus nerve stimulation could provide respite from ADHD symptoms can visit Pulsetto’s website at https://pulsetto.tech/blogs/blog/vagus-nerve-stimulation-for-adhd-do-exercises-non-invasive-treatment-work

Contact Info:
Name: Agnė Ginaitė
Email: Send Email
Organization: Pulsetto
Address: 3 Aludarių gatvė, Vilnius, Vilniaus apskritis 01113, Lithuania
Website: https://pulsetto.tech/

Source: PressCable

Release ID: 89145945

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.